Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

Blockbuster weight-loss drugs like Ozempic, Wegovy and Mounjaro are drastically changing what Americans are putting in their ...

The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...

From prescriptions to hospitals to Medicaid, President Donald Trump's healthcare vision, with eligibility changes, will come ...

Vanda Pharmaceuticals, Inc. VNDA announced that the FDA has approved its candidate tradipitant for the prevention of vomiting ...

Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...

Drugmakers plan to raise U. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and ...

Ozempic and Wegovy – two brand-name semaglutide drugs prescribed for diabetes and weight loss – will lose market exclusivity ...

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by ...

This time last year I was newly into my Mounjaro journey. Nudging the scales at over 13st, and a size 18, I knew I needed to ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some o ...

A farmer is among the first people in the UK to join a trial which is testing whether a diabetes drug can treat a "deadly" ...